ANTX logo

AN2 Therapeutics (ANTX)

Profile

Full Name

AN2 Therapeutics, Inc.

Ticker Symbol

ANTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 25, 2022

Indexes

Not included

Website

http://www.an2therapeutics.com

Employees

22

Key Details

Price

$1.28(+5.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.72(+37.23% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.28
ANTX price is $1.28

30-Day Relative Volume

0.46
ANTX 30-day relative volume is 0.46

Price Performance

Price Most recent change

+5.79%
ANTX price was up +5.79% on Apr 11, 2025

Price YTD change

-7.25%
ANTX price is down -7.25% since January 1st

Price 1-year change

-57.33%
ANTX price is down -57.33% year-on-year

Price 3-year change

-90.63%
ANTX price is down -90.63% over the past 3 years

Price Range

Price All-time high

$23.58
ANTX price is currently -94.57% below its historical high of $23.58

Price 3-year low

$0.87
ANTX price is currently +47.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$38.53M
ANTX market capitalization is $38.53 million

Market cap 3-year change

-84.93%
ANTX market capitalization is down -84.93% over the past 3 years

Market cap All-time high

$653.12M
ANTX market capitalization is currently -94.10% below its historical high of $653.12 million

Market cap sector rank

35.17%
ANTX market capitalization is higher than 35.17% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.95%
ANTX shares outstanding is up +0.95% year-on-year

Shares Outstanding 3-Year Change

+60.85%
ANTX shares outstanding is up +60.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
ANTX beta is 0.71

200-day SMA

$1.41
ANTX price is currently -9.36% below its 200-day simple moving average

50-day SMA

$1.26
ANTX price is currently +1.56% above its 50-day simple moving average

RSI

45.77
ANTX 14-day relative strength index is 45.77

Volume

0.46
ANTX 30-day relative volume is 0.46

ATR

$0.09
ANTX average true range is $0.09

10-day Historical Volatility

73.64%
ANTX 10-day historical volatility is 73.64%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ANTX annual revenue value is unknown

Revenue Analysts estimate

-
ANTX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ANTX annual revenue 1-year change is unknown

Revenue Sector rank

-
ANTX annual revenue is unknown

EPS

EPS

-$1.72
ANTX annual earnings per share is -$1.72

EPS Analysts estimate

-$0.95
ANTX annual earnings per share is currently +80.10% higher than the consensus analysts' forecast

EPS 1-year change

+37.23%
ANTX annual earnings per share is up +37.23% year-on-year

EPS Sector rank

41.45%
ANTX annual earnings per share is higher than 41.45% of companies in Healthcare sector

Profit

Gross profit

-
ANTX annual gross profit value is unknown

Gross margin

-
ANTX annual gross profit margin value is unknown

Operating profit

-$54.55M
ANTX annual operating income is -$54.55 million

Operating margin

-
ANTX annual operating profit margin value is unknown

Net income

-$51.32M
ANTX annual net profit is -$51.32 million

Net margin

-
ANTX annual net profit margin value is unknown

Expenses

Total expenses

$54.55M
ANTX annual total expenses is $54.55 million

Operating expenses

$54.55M
ANTX annual total operating expenses is $54.55 million

Cost of goods sold

-
ANTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$14.07M
ANTX annual SGA is $14.07 million

Depreciation and amortization

-
ANTX annual depreciation & amortization value is unknown

Interest expense

-
ANTX annual interest expense value is unknown

Income tax

-
ANTX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$54.55M
ANTX annual earnings before interest & taxes is -$54.55 million

EBITDA

-$54.55M
ANTX annual EBITDA is -$54.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$92.09M
ANTX annual total assets is $92.09 million

Non current assets

$5.83M
ANTX annual long term assets is $5.83 million

Current assets

$86.26M
ANTX annual total current assets is $86.26 million

Cash and cash equivalents

$21.35M
ANTX annual cash & cash equivalents is $21.35 million

Accounts receivable

-
ANTX annual accounts receivable value is unknown

Inventory

-
ANTX annual inventory value is unknown

Liabilities

Total liabilities

$10.24M
ANTX annual total liabilities is $10.24 million

Long term liabilities

$0.00
ANTX annual total long term liabilities is $0.00

Current liabilities

$10.24M
ANTX annual total current liabilities is $10.24 million

Accounts payable

$3.32M
ANTX annual accounts payable is $3.32 million

Debt

Total debt

$0.00
ANTX annual total debt is $0.00

Total debt 1-year change

0%
ANTX {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
ANTX annual long term debt value is unknown

Short term debt

-
ANTX annual short term debt value is unknown

Equity & Capital

Shareholders equity

$81.85M
ANTX annual stockholders equity is $81.85 million

Book value

$81.85M
ANTX annual book value is $81.85 million

Retained earnings

-$205.78M
ANTX annual retained earnings is -$205.78 million

Working capital

$76.02M
ANTX annual working capital is $76.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$49.26M
ANTX annual cash flow from operations is -$49.26 million

Cash from operations 1-year change

+7.56%
ANTX annual cash flow from operations is up +7.56% year-on-year

Cash from investing

$54.59M
ANTX annual cash flow from investing activities is $54.59 million

Cash from investing 1-year change

+226.14%
ANTX annual cash flow from investing activities is up +226.14% year-on-year

Cash from financing

$372.00K
ANTX annual cash flow from financing activities is $372.00 thousand

Cash from financing 1-year change

-99.56%
ANTX annual cash flow from financing activities is down -99.56% year-on-year

CAPEX

CAPEX

-
ANTX annual capital expenditures value is unknown

CAPEX 1-year change

-
ANTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$49.26M
ANTX annual free cash flow is -$49.26 million

Free cash flow 1-year change

+7.56%
ANTX annual free cash flow is up +7.56% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ANTX annual gross profit margin value is unknown

Operating margin

-
ANTX annual operating profit margin value is unknown

Net margin

-
ANTX annual net profit margin value is unknown

ROA & ROE

ROA

-55.73%
ANTX annual return on assets is -55.73%

ROE

-62.70%
ANTX annual return on equity is -62.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ANTX price to earnings ratio value is unknown

PE ratio Sector rank

-
ANTX price to earnings ratio is unknown

PB Ratio

PB ratio

0.47
ANTX price to book ratio is 0.47

PB ratio Sector rank

28.78%
ANTX price to book ratio is higher than 28.78% of companies in Healthcare sector

PS Ratio

PS ratio

-
ANTX price to sales ratio value is unknown

PS ratio Sector rank

-
ANTX price to sales ratio is unknown

Enterprise value

Enterprise value

$17.18M
ANTX enterprise value is $17.18 million

Enterprise value Sector rank

30.88%
ANTX enterprise value is higher than 30.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.31
ANTX EV/EBITDA is -0.31

EV/EBITDA Sector rank

55.43%
ANTX EV/EBITDA is higher than 55.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.43
ANTX annual current ratio is 8.43

Quick ratio

-
ANTX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ANTX annual debt to equity ratio is 0.00

Interest coverage ratio

-
ANTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ANTX piotroski f-score value is unknown

Altman Z-Score

-
ANTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 26, 25 Citizens Capital Markets
Market Outperform
Feb 25, 25 Citizens Capital Markets
Market Outperform
Feb 3, 25 JMP Securities
Market Outperform
Nov 19, 24 JMP Securities
Market Outperform
Nov 18, 24 TD Cowen
Hold
Aug 9, 24 JMP Securities
Market Outperform
Jul 3, 24 Leerink Partners
Outperform
May 16, 24 Evercore ISI Group
In-Line
Apr 2, 24 JMP Securities
Market Outperform
Apr 1, 24 Oppenheimer
Perform

Institutional Ownership

Similar stocks

NVNO logo
enVVeno Medical (NVNO)
ITRM logo
Iterum Therapeutics (ITRM)
TELA logo
TELA Bio (TELA)
MRSN logo
Mersana Therapeutics (MRSN)
RPTX logo
Repare Therapeutics (RPTX)
PRLD logo
Prelude Therapeutics Incorporated (PRLD)
OPGN logo
OpGen (OPGN)
Rein Therapeutics (RNTX)
Advanced Biomed (ADVB)
  • What is the ticker symbol for AN2 Therapeutics?
  • Does AN2 Therapeutics pay dividends?
  • What sector is AN2 Therapeutics in?
  • What industry is AN2 Therapeutics in?
  • What country is AN2 Therapeutics based in?
  • When did AN2 Therapeutics go public?
  • Is AN2 Therapeutics in the S&P 500?
  • Is AN2 Therapeutics in the NASDAQ 100?
  • Is AN2 Therapeutics in the Dow Jones?
  • When was AN2 Therapeutics's last earnings report?
  • When does AN2 Therapeutics report earnings?
  • Should I buy AN2 Therapeutics stock now?

What is the ticker symbol for AN2 Therapeutics?

The ticker symbol for AN2 Therapeutics is NASDAQ:ANTX

Does AN2 Therapeutics pay dividends?

No, AN2 Therapeutics does not pay dividends

What sector is AN2 Therapeutics in?

AN2 Therapeutics is in the Healthcare sector

What industry is AN2 Therapeutics in?

AN2 Therapeutics is in the Biotechnology industry

What country is AN2 Therapeutics based in?

AN2 Therapeutics is headquartered in United States

When did AN2 Therapeutics go public?

AN2 Therapeutics's initial public offering (IPO) was on March 25, 2022

Is AN2 Therapeutics in the S&P 500?

No, AN2 Therapeutics is not included in the S&P 500 index

Is AN2 Therapeutics in the NASDAQ 100?

No, AN2 Therapeutics is not included in the NASDAQ 100 index

Is AN2 Therapeutics in the Dow Jones?

No, AN2 Therapeutics is not included in the Dow Jones index

When was AN2 Therapeutics's last earnings report?

AN2 Therapeutics's most recent earnings report was on Mar 25, 2025

When does AN2 Therapeutics report earnings?

The next expected earnings date for AN2 Therapeutics is May 14, 2025

Should I buy AN2 Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page